申请人:PFIZER INC.
公开号:US20160229847A1
公开(公告)日:2016-08-11
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula II as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
本发明揭示了化合物及其药学上可接受的盐,其中该化合物具有规定在规范中的II式结构。还揭示了相应的药物组合物、治疗方法、合成方法和中间体。